Tesla Stock Slides to $389 as SpaceX's $75B IPO Stokes Capital-Rotation Fears Two Days Out

Tesla (TSLA) traded near $388.88 by midday Wednesday, swinging through an exceptionally wide intraday band between $384.24 and $418.50 on volume of 59.94 million shares — well above its 45.83-million average — as the market braced for the most consequential event in the Musk universe in years. The stock sits roughly 22% below the all-time high of $498.83 it set in December 2025 and has slid from around $431 at the start of June, a decline driven less by any single operational stumble than by the gravitational pull of SpaceX's imminent public debut. With a 52-week range stretching from $288.77 to $498.83, the shares are trading in the lower-middle of their annual band, caught between a genuine improvement in China demand and a valuation that leaves almost no margin for error.

The volatility itself tells the story. A near-$34 intraday range on a single session reflects a market unable to settle on what the next 48 hours mean for the stock, with money rotating in and out as headlines around the SpaceX listing, a potential merger and the broader technology selloff cross the tape. Tesla fell about 3% to $396.68 on Tuesday and slipped further into Wednesday, extending a pullback that has erased the bounce the stock enjoyed earlier in the week. The shares now sit below the cluster of moving averages that defines the medium-term trend, a technically fragile position heading into a binary catalyst.

The SpaceX Shadow: A $75 Billion IPO Two Days Out

The dominant force on Tesla this week is a company Tesla does not own. SpaceX, also run by Elon Musk, is scheduled to begin public trading on Nasdaq on June 12 in a record initial public offering raising roughly $75 billion, with the company targeting a valuation near $1.75 trillion. Demand has been overwhelming, with reports of $150 billion to more than $250 billion in interest, and the offering plans to allocate around 30% of shares to retail buyers — a structure that bets directly on Musk's loyal base and puts Tesla under fresh scrutiny.

The fear gripping Tesla holders is capital rotation. With SpaceX about to offer public exposure to Musk's space and satellite empire for the first time, the concern is that money currently parked in Tesla as the primary Musk proxy will rotate into the new vehicle, draining demand from a stock that already trades on expectations from future business lines. That dynamic is why Tesla slid as SpaceX IPO buzz intensified, with one session framed explicitly as the IPO putting "pressure on Musk plays." Compounding the uncertainty is persistent merger speculation: reports of discussions around a potential SpaceX-Tesla combination, coinciding with SpaceX's filing, have weighed on sentiment, with Tesla falling on days when merger concerns dominated. The operating ties are real but small — Tesla booked $87 million in revenue and $65 million in cost of revenue from SpaceX's Megapack energy-storage purchases in the first quarter — but the market is trading the IPO's gravitational effect on capital flows, not the modest commercial relationship.

The valuation contrast sharpens the debate. SpaceX's target implies roughly 94.53 times 2025 sales, well above Tesla's 16.73 times, a gap that has prompted some to question SpaceX's fundamentals even as demand surges. Whether the listing drains capital from Tesla or reinforces a "Musk halo effect" across both names is the question the next two sessions will begin to answer.

The China Bounce That Didn't Hold

Beneath the IPO noise, Tesla delivered a genuine piece of good news that briefly lifted the stock. Retail sales of Tesla vehicles in China jumped 22.5% in May to 47,281 units year-over-year, snapping a two-month slide, according to data from the China Passenger Car Association. That improvement drove the stock back over $400 earlier in the week, a move that outpaced the broader Nasdaq-tracking QQQ and suggested the tape was pricing optimism about China demand, autonomy and Musk's technology push rather than simply riding a market rebound.

The bounce did not hold. As the SpaceX IPO and the broader technology selloff reasserted themselves, the China-driven gains faded and the stock slid back toward $389. The episode captured Tesla's central vulnerability: even materially better demand data in its second-largest market could not sustain the stock against the dual headwinds of a sky-high valuation and the capital-rotation threat. China remains a double-edged market for Tesla — the May rebound was real, but it came after a two-month slide and against the backdrop of intensifying competition from domestic rivals offering lower-cost models, the same pressure that has weighed on Tesla's delivery trajectory for over a year. A single strong month is encouraging, but the market wants evidence of a sustained recovery before it re-rates the stock on China alone.

Q1 2026: A Beat on Earnings, a Miss on Revenue

Tesla's most recent results, reported April 22, painted a mixed picture that the stock is still digesting. Non-GAAP earnings per share came in at $0.41, beating the consensus estimate of $0.39 by two cents, while net income reached $477 million, up 17% from the prior-year period. Gross margin expanded to 21.1%, and free cash flow for the quarter registered $1.44 billion, a healthier figure than some had feared given the company's spending plans.

The blemish was the top line. Revenue rose 15.8% year-over-year to $22.39 billion but fell short of the roughly $22.96 billion analysts had modeled, and vehicle deliveries of approximately 358,000 units came in below expectations. The combination of an earnings beat and a revenue miss reflected the tension at the heart of the current Tesla story — profitability holding up while the core automotive volume disappoints. Musk struck a notably calmer tone on the earnings call than in prior quarters, but guidance on the robotaxi rollout timeline and the pace of full self-driving commercialization remained the focal point, underscoring that the market is increasingly valuing Tesla on what it might become rather than what it currently sells.

The $25 Billion Capex Bet on Real-World AI

The quarter confirmed a deliberate strategic shift. Tesla reaffirmed plans to spend over $25 billion in capital expenditure in 2026, directed primarily at AI compute infrastructure, expansion of its Dojo supercomputer and robotaxi fleet deployment — a reallocation of resources toward longer-dated autonomous and robotics revenue streams. The company is telling the market it is leaning into "real-world AI" through FSD Supervised, its Robotaxi service and the Optimus humanoid robot, positioning itself as much an AI and robotics company as an automaker.

That bet carries a financial cost. While first-quarter free cash flow was positive at $1.44 billion, the scale of the capex ramp threatens full-year free cash flow, with one major bank writing that it now expects negative overall free cash flow for Tesla this year as spending exceeds $20 billion partly to fund AI training infrastructure. The strategic logic is that the autonomy and robotics businesses justify the spend — one firm places Tesla's broader product suite, including FSD, charging and licensing, at almost $160 per share — but the near-term effect is a company sacrificing cash generation today for an autonomous future that remains years from material revenue. The market's willingness to fund that transition is precisely what the SpaceX IPO threatens to test, as capital weighs competing Musk-led growth stories.

Robotaxi Dreams vs a 378x Multiple

The crux of the Tesla forecast is the collision between an ambitious autonomy narrative and an extreme valuation. The stock trades at a price-to-earnings ratio around 378, a multiple that leaves no cushion if China demand slips, robotaxi approvals stall, or money rotates out of pricey technology names. The bull case rests on the robotaxi opportunity: Tesla has hit testing milestones in Austin, including its first rides without a safety driver, and gained new approvals to expand autonomous-vehicle testing in Arizona and Nevada, reinforcing its position in the "physical AI" space. One major bank expects Tesla to deploy around 1,000 robotaxis by the end of 2026, with a path toward one million by 2035, and a prominent analyst has gone so far as to declare that "autonomous cars are solved."

The bear case is that the multiple has run far ahead of the reality. With full-year 2026 earnings consensus near $1.25 per share and the robotaxi business still in its earliest commercial stage, the 378x multiple prices in a flawless execution of a business that barely exists at scale. The phrase capturing the moment — robotaxi dreams colliding with a sky-high valuation — frames the risk precisely: every disappointment in the autonomy timeline, every regulatory delay, and every quarter of soft deliveries lands harder on a stock priced for perfection. The Optimus humanoid program adds further optionality that some valuations assign at no cost, but optionality is not earnings, and the market's patience with a story stock during a broad technology selloff is finite.

Deliveries Remain the Soft Spot

For all the focus on autonomy, the automotive core remains the soft underbelly of the Tesla story. The roughly 358,000 vehicles delivered in the first quarter came in below expectations, extending a stretch of disappointing volume that began with a steep drop earlier in 2026 — the company's steepest single-day stock decline of the year followed a disappointing deliveries report in April. Tesla is coming off a year of declining deliveries, driven in part by intensifying competition from Chinese rivals offering lower-cost models, and the fourth quarter of 2025 saw deliveries fall roughly 16% year-over-year.

The May China rebound of 22.5% offers a tentative counterpoint, but it sits against that broader backdrop of volume pressure. The market's concern is structural: if the automotive business is shrinking or stagnating while the company pours $25 billion into autonomy and robotics, the transition becomes a race against time, with the legacy cash engine weakening just as the future businesses demand heavy investment. The second-quarter delivery figures, and the guidance around them, will be a critical test of whether the China bounce marks a genuine inflection or a single strong month within a declining trend. Analysts have already trimmed near-term estimates, with one research house cutting its third-quarter EPS estimate to $0.23 from $0.26.

Analyst Targets: A Hold at $404 With a $364–$500 Spread

The research community reflects the stock's deep uncertainty through a Hold consensus and an unusually wide dispersion of targets. As of early June, the consensus rating sat at Hold, built on a roughly even split of buy, hold and sell recommendations, with average 12-month price targets clustering around $404 — figures of $403.89, $404.37 and $409.18 appearing across major aggregators. From a price near $389, that consensus implies only modest upside, a signal that the average analyst sees the stock as roughly fairly valued at current levels.

The spread around that average is where the disagreement lives. On the bullish end, TD Cowen maintained a Buy with a $490 target following the first-quarter results, citing the robotaxi infrastructure build-out and the AI compute investment cycle, while a Piper Sandler analyst reiterated a Buy and a $500 target, valuing Tesla's 17 business lines at roughly $400 per share combined and treating the Optimus program as essentially free optionality. On the cautious end, UBS raised its target to $364 while keeping a Neutral rating, flagging margin uncertainty and execution risk around the $25 billion capex program, and Goldman Sachs cut its target to $405 with a Neutral rating after flagging the negative free-cash-flow outlook. The gap between $364 and $500 is not a rounding error — it reflects a fundamental disagreement about whether Tesla is an automaker trading at a stretched multiple or an AI and robotics company in the early innings of a transformation.

The Technical Map: Below the $395–$426 SMA Cluster

The chart has turned defensive. Tesla's moving-average family sits in a tight, non-aligned cluster — with the 20-, 50-, 100- and 200-day simple moving averages printing at approximately $426, $395, $403 and $414 respectively — and the price near $389 has slipped beneath all of them. That positioning, with the price below a fragmented rather than aligned moving-average structure, signals a trend that has lost its upward momentum and entered a corrective phase.

The immediate support is the intraday low near $384, the level the stock defended on Wednesday's wide-ranging session. A decisive break beneath $384 would open the path lower toward the $288.77 52-week low, though substantial support would likely emerge well before that extreme. On the upside, the resistance is layered through the moving-average cluster: the 50-day near $395 is the first hurdle, followed by the 100-day near $403, the 200-day near $414, the intraday high near $418, the 20-day near $426 and the early-June level near $431. Reclaiming that $395 to $426 band would be necessary to argue that the correction has run its course. The wide intraday range and elevated volume underscore that the stock is in a high-volatility regime where the SpaceX IPO and the broader technology tape, rather than Tesla's own fundamentals, are setting the near-term direction.

Forecast: Volatile Into the IPO, With the Q2 Print the Next Test

The configuration points to continued volatility through the SpaceX listing, with Tesla likely to trade the IPO's gravitational effect on capital flows before the stock can reconnect with its own fundamentals. The June 12 debut is the immediate binary catalyst: a successful, well-received SpaceX IPO that reinforces the Musk halo could lift Tesla alongside it, while a listing that visibly drains capital from Tesla — or that triggers the merger speculation into something concrete — could pressure the shares through the $384 support. The near-term path is likely to hold a wide band between $384 and the $403 to $418 resistance, with the moving-average cluster around $395 to $426 capping rallies until a catalyst forces a break.

Beyond the IPO, the next fundamental test is the second-quarter print, where the market will scrutinize robotaxi unit economics, Optimus progress and any revision to the $25 billion full-year capital expenditure guidance. The bull case requires the China rebound to prove durable, the robotaxi rollout to hit its targets toward 1,000 deployed vehicles by year-end, and the autonomy narrative to justify the 378x multiple. The bear case requires only that deliveries stay soft, free cash flow turn negative as guided, and the SpaceX IPO pull capital away — a combination that would leave a story stock exposed during a broad technology selloff. With a Hold consensus near $404 against a price of $389, the market is positioned for limited upside and real downside risk, and the resolution depends on whether the real-world AI thesis can outrun a valuation that prices in its success. Until the IPO clears and the Q2 numbers arrive, Tesla trades the headlines, swinging between $384 and $418 and waiting for the next Musk catalyst to break the range.

What Would Break the Range

For Tesla to break higher and reclaim the $426 to $431 zone, the autonomy and demand stories need to deliver while the SpaceX overhang clears. A SpaceX IPO that reinforces rather than cannibalizes the Musk halo, a durable continuation of the 22.5% China sales rebound into June and July, and concrete robotaxi progress toward the 1,000-vehicle target would each supply a catalyst. A second-quarter print that shows deliveries stabilizing and the capex spend translating into visible autonomy milestones would give the elevated multiple room to hold.

For the stock to break beneath $384 and risk a deeper retracement, the bearish forces simply have to persist. A SpaceX IPO that visibly rotates capital out of Tesla, a relapse in China deliveries, confirmation of negative full-year free cash flow, or a continuation of the broad technology and AI selloff would each pressure the shares lower. The 378x multiple is the vulnerability that amplifies every disappointment, and the "Musk tolerance" factor — the degree to which the market is willing to underwrite a story tied so closely to one founder's competing ventures — adds a layer of risk no model fully captures. Until the SpaceX listing resolves and the Q2 numbers clarify whether the China bounce was an inflection or a blip, Tesla remains a high-beta proxy for sentiment around Musk, autonomy and the AI trade, anchored near $389 and watching $384 below and the $395 to $426 cluster above.

That's TradingNEWS